Clinical Trial Update: Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer [NA]

View source ↗

Summary

Clinical trial update on risk-reducing strategies, including fimbriectomy, for women with germline mutations predisposing to ovarian or pelvic cancers; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer
• Peritoneal Cancer
• Tubo-ovarian Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Tubo-ovarian Carcinoma, High-grade Serous Carcinoma | NA | Status: NOT_YET_RECRUITING